INNOVIVA INC's ticker is INVA and the CUSIP is 45781M101. A total of 220 filers reported holding INNOVIVA INC in Q4 2021. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $101,359,380 | +5.8% | 6,180,450 | -1.7% | 0.00% | 0.0% |
Q1 2024 | $95,798,839 | -11.0% | 6,286,013 | -6.4% | 0.00% | 0.0% |
Q4 2023 | $107,667,586 | +23.4% | 6,712,443 | -0.1% | 0.00% | 0.0% |
Q3 2023 | $87,259,506 | +1.0% | 6,717,437 | -1.1% | 0.00% | 0.0% |
Q2 2023 | $86,420,838 | +6.7% | 6,788,754 | -5.7% | 0.00% | 0.0% |
Q1 2023 | $80,972,675 | -13.6% | 7,197,571 | +1.8% | 0.00% | -33.3% |
Q4 2022 | $93,706,809 | +15.3% | 7,072,212 | +1.1% | 0.00% | +50.0% |
Q3 2022 | $81,247,000 | -21.0% | 6,997,953 | +0.4% | 0.00% | -33.3% |
Q2 2022 | $102,890,000 | -22.1% | 6,970,950 | +2.2% | 0.00% | 0.0% |
Q1 2022 | $132,032,000 | +12.6% | 6,823,390 | +0.3% | 0.00% | 0.0% |
Q4 2021 | $117,303,000 | +4.8% | 6,800,195 | +1.5% | 0.00% | 0.0% |
Q3 2021 | $111,953,000 | +22.8% | 6,699,720 | -1.4% | 0.00% | +50.0% |
Q2 2021 | $91,163,000 | +12.7% | 6,798,017 | +0.5% | 0.00% | 0.0% |
Q1 2021 | $80,871,000 | -1.0% | 6,767,451 | +2.6% | 0.00% | 0.0% |
Q4 2020 | $81,718,000 | +19.4% | 6,595,483 | +0.7% | 0.00% | 0.0% |
Q3 2020 | $68,417,000 | -28.3% | 6,547,044 | -4.1% | 0.00% | -33.3% |
Q2 2020 | $95,392,000 | +19.2% | 6,823,482 | +0.3% | 0.00% | 0.0% |
Q1 2020 | $80,003,000 | -17.0% | 6,802,911 | -0.1% | 0.00% | 0.0% |
Q4 2019 | $96,386,000 | +35.9% | 6,806,939 | +1.2% | 0.00% | 0.0% |
Q3 2019 | $70,909,000 | -31.5% | 6,727,455 | -5.4% | 0.00% | -25.0% |
Q2 2019 | $103,532,000 | +4.1% | 7,110,733 | +0.3% | 0.00% | 0.0% |
Q1 2019 | $99,491,000 | -19.3% | 7,091,307 | +0.4% | 0.00% | -33.3% |
Q4 2018 | $123,256,000 | +15.4% | 7,063,337 | +0.8% | 0.01% | +50.0% |
Q3 2018 | $106,804,000 | +13.0% | 7,008,172 | +2.3% | 0.00% | 0.0% |
Q2 2018 | $94,545,000 | -22.3% | 6,851,036 | -6.1% | 0.00% | -20.0% |
Q1 2018 | $121,626,000 | +19.7% | 7,296,037 | +1.9% | 0.01% | +25.0% |
Q4 2017 | $101,619,000 | -1.9% | 7,161,282 | -2.4% | 0.00% | -20.0% |
Q3 2017 | $103,588,000 | +8.5% | 7,336,331 | -1.7% | 0.01% | 0.0% |
Q2 2017 | $95,483,000 | -4.5% | 7,459,616 | +3.1% | 0.01% | 0.0% |
Q1 2017 | $100,027,000 | +40.2% | 7,232,647 | +8.5% | 0.01% | +25.0% |
Q4 2016 | $71,322,000 | +5.8% | 6,665,663 | +8.7% | 0.00% | 0.0% |
Q3 2016 | $67,390,000 | +10.5% | 6,132,035 | +5.9% | 0.00% | 0.0% |
Q2 2016 | $60,991,000 | -14.8% | 5,792,193 | +1.8% | 0.00% | -20.0% |
Q1 2016 | $71,626,000 | – | 5,689,113 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Litespeed Management, L.L.C. | 2,979,212 | $37,508,000 | 7.32% |
Baupost Group | 19,815,983 | $249,483,000 | 3.60% |
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 2,530,104 | $31,854,000 | 2.48% |
Empyrean Capital Partners, LP | 3,664,758 | $46,139,000 | 1.93% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 12,182,146 | $153,373,000 | 1.30% |
Partner Investment Management, L.P. | 33,973 | $428,000 | 0.70% |
PFM Health Sciences, LP | 1,486,214 | $18,711,000 | 0.58% |
Diligent Investors, LLC | 37,660 | $474,000 | 0.52% |
Roundview Capital LLC | 103,275 | $1,300,000 | 0.48% |
NJ State Employees Deferred Compensation Plan | 102,000 | $1,378,000 | 0.29% |